Lee's Pharmaceutical Holdings Limited
LPCUF
Price:
$0.1903
Market Cap:
$989.24M
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China. The company focuses on various disease areas, including cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology, obstetrics, and urology. It operates through Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells self-developed and generic pharmaceutical products, such as Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Eyprotor for corneal ulc...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-07-16
Stock Exchange
OTC
Ticker
LPCUF
PE Ratio
[9.51]
ROE
[5.44%]
Current Ratio
[1.06]
Dividend Yield
[2.80%]
Enterprise Value
[929.29M]
Dividend History
The ROE as of December 2025 (TTM) for Lee's Pharmaceutical Holdings Limited (LPCUF) is 5.44%
According to Lee's Pharmaceutical Holdings Limited’s latest financial reports and current stock price. The company's current ROE is 5.44%. This represents a change of 309.80% compared to the average of 1.33% of the last 4 quarters.
Lee's Pharmaceutical Holdings Limited (LPCUF) Historical ROE (quarterly & annually)
How has LPCUF ROE performed in the past?
The mean historical ROE of Lee's Pharmaceutical Holdings Limited over the last ten years is 16.17%. The current 5.44% ROE has changed -66.35% with respect to the historical average. Over the past ten years (40 quarters), LPCUF's ROE was at its highest in in the June 2021 quarter at 59.83%. The ROE was at its lowest in in the December 2021 quarter at -7.51%.
Average
16.17%
Median
9.45%
Minimum
0.82%
Maximum
80.63%
Lee's Pharmaceutical Holdings Limited (LPCUF) ROE by Quarter and Year
Discovering the peaks and valleys of Lee's Pharmaceutical Holdings Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.24%
Maximum Annual ROE = 80.63%
Minimum Annual Increase = -96.69%
Minimum Annual ROE = 0.82%
| Year | ROE | Change |
|---|---|---|
| 2024 | 5.64% | 588.23% |
| 2023 | 0.82% | -69.27% |
| 2022 | 2.67% | -96.69% |
| 2021 | 80.63% | 1.24% |
| 2020 | 6.02% | 118.02% |
| 2019 | 2.76% | -85.42% |
| 2018 | 18.92% | 46.81% |
| 2017 | 12.89% | -18.08% |
| 2016 | 15.73% | 0.80% |
| 2015 | 15.61% | -24.37% |
Lee's Pharmaceutical Holdings Limited (LPCUF) Average ROE
How has LPCUF ROE performed in the past?
The current ROE of Lee's Pharmaceutical Holdings Limited (LPCUF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.04%
5-year avg
19.15%
10-year avg
16.17%
Lee's Pharmaceutical Holdings Limited (LPCUF) ROE vs. Peers
How is LPCUF’s ROE compared to its peers?
Lee's Pharmaceutical Holdings Limited’s ROE is greater than BioHarvest Sciences Inc. (-156.08%), less than Green Rain Energy Holdings Inc. (6.47%), greater than Creso Pharma Limited (-130.99%), greater than Eupraxia Pharmaceuticals Inc. (-118.64%), less than Leafly Holdings, Inc. (33.75%), less than Adocia S.A. (180.00%), greater than Diaceutics PLC (-3.94%), greater than Anteris Technologies Ltd (-139.03%), greater than Japan Medical Dynamic Marketing, Inc. (-2.67%), less than Prescient Therapeutics Limited (0%),
| Company | ROE | Market cap |
|---|---|---|
| -156.08% | $109.16M | |
| 6.47% | $83.49K | |
| -130.99% | $131.72M | |
| -118.64% | $108.29M | |
| 33.75% | $114.90M | |
| 180.00% | $103.66M | |
| -3.94% | $115.56M | |
| -139.03% | $120.50M | |
| -2.67% | $94.12M | |
| 0% | $117.53M |
Build a custom stock screener for Lee's Pharmaceutical Holdings Limited (LPCUF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lee's Pharmaceutical Holdings Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Lee's Pharmaceutical Holdings Limited (LPCUF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Lee's Pharmaceutical Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Lee's Pharmaceutical Holdings Limited's ROE?
How is the ROE calculated for Lee's Pharmaceutical Holdings Limited (LPCUF)?
What is the highest ROE for Lee's Pharmaceutical Holdings Limited (LPCUF)?
What is the 3-year average ROE for Lee's Pharmaceutical Holdings Limited (LPCUF)?
What is the 5-year average ROE for Lee's Pharmaceutical Holdings Limited (LPCUF)?
How does the current ROE for Lee's Pharmaceutical Holdings Limited (LPCUF) compare to its historical average?